TrialStroke2022

Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.

Ji Man Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.